Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
The LARVOL CLIN platform offers a robust suite of AI-driven data intelligence and analytics specifically designed for professionals in oncology and drug development, consolidating over 100,000 cancer clinical trials along with comprehensive results, digitized Kaplan-Meier curves, forest plots, and live social media feedback from a network of more than 5,000 oncologists. Users benefit from a unified interface that allows for searches by condition, intervention, or trial ID, complemented by expert-curated insights and visually engaging dashboards that facilitate informed decision-making. Additionally, the platform encompasses features such as conference tracking, extensive biomarker and diagnostics databases, and market intelligence reports sourced from over 25,000 entities, including regulatory communications, clinical trial registries, and various scientific congresses. Designed to aid pharmaceutical and biotech teams in deciphering trial outcomes, trends, mechanisms of action, biomarker identification, and disease pipelines, it employs advanced search filters, heat maps, and real-time alerts. This comprehensive approach ensures that users remain well-informed and equipped to make strategic decisions in a rapidly evolving field.
Description
Progressing artificial intelligence to remove the need for trial and error in healthcare, our digital twins facilitate swift and assured clinical trials. We focus on areas such as neuroscience, immunology, and metabolic diseases, among others. TwinRCTs expedite full enrollment by requiring fewer participants to provide equivalent statistical power compared to conventional trial methodologies. This approach significantly reduces the time needed for late-stage study enrollment. Additionally, TwinRCTs enhance the ability to detect treatment effects in early-stage studies by bolstering statistical power without necessitating an increase in participant numbers. They enable researchers to make informed decisions based on initial study outcomes and help attract more participants to trials. By utilizing smaller control groups, TwinRCTs also improve participants' odds of receiving the experimental treatment. Our commitment to positioning clinical trials with digital twins for regulatory success is unwavering. Unlearn is at the forefront of transforming the medical field through the innovative application of artificial intelligence, creating and implementing novel generative models that are trained on vast datasets derived from previous patient studies. This evolution in methodology not only streamlines research but also enhances the overall effectiveness of clinical trials.
API Access
Has API
API Access
Has API
Integrations
Alignable
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
LARVOL
Founded
2004
Country
United States
Website
www.larvol.com
Vendor Details
Company Name
Unlearn
Country
United States
Website
www.unlearn.ai/
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning